Skip to main content
| News

«We will show the new product at the Olympic Games 2021 in Tokyo»

15.12.2020

The new Basel Area Business & Innovation Podcast offers exciting conversations with interesting interview partners. The first guest is surgeon and entrepreneur Hans-Florian Zeilhofer. The Bavarian has lived and worked in Basel for 18 years. He has founded various startups and initiated many research projects in the high-tech sector. One of them will be presented at the Olympic Games in Tokyo «as a new product from the Basel Area for the world», as Zeilhofer reveals in the podcast.

Podcast cover - Top researcher and entrepreneur: Hans-Florian Zeilhofer

Zeilhofer got the idea for his latest project a few months ago when he visited the Humard company in the canton of Jura. «I realized that they had developed a technology for the watchmaking industry which could easily be transformed for educating young surgeons.» Because the product will be shown as a world premiere next year at the Olympic Games in Tokyo, Zeilhofer cannot go into details. But he reveals that it can bring new aspects of automatization into the operating room. And he announces that he has more plans for the Olympics.

Hans-Florian Zeilhofer combines research and entrepreneurship in an exemplary way. In the podcast, he talks about his desire to be a scientist and an entrepreneur at the same time. He also explains what he focuses on when putting together a team. «I like people who are honest, I like people who have passion. These are the most important things I look at,» says Zeilhofer.

Zeilhofer is raving when he talks about the Basel Area as a business and innovation location. He particularly appreciates the short distances, the proximity to the border and the dynamic ecosystem. «The Basel Area is great, not only by size, also by spirit.»

The new podcast sets a stage for the Basel Area. What makes the Basel Area a good business and innovation location? Which innovations could cause a sensation? What is important to consider when founding a startup? Are good scientists also good CEOs? Such questions are discussed with the guests in the Basel Area Business & Innovation Podcast. The episode with Hans-Florian Zeilhofer is available in both German and English. You can subscribe to the Basel Area Business & Innovation Podcast on your preferred platform, for example on Spotify, Deezer, Apple Podcast and Google Play or on baselarea.swiss/media.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation, Invest, Sustainability

KUORI developing biodegradable plastics

The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Cell and gene therapies gain momentum in Basel

Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...

Read More
BLKB expanding support for startups
Basel Area Business & Innovation, Innovation, Invest

BLKB expanding support for startups

BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...

Read More
Combatting the rise of antimicrobial resistance
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Combatting the rise of antimicrobial resistance

Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

AMR Action Fund invests in new antibiotics developed by BioVersys

The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Investors give Resistell 8.5 million Swiss francs

Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...

Read More
1 2 3 60

Do you have a question? We'd like to hear from you.